Pluribus Labs’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Pluribus Labs's MDT Position: Q2 2022 in Review
Pluribus Labs increased its Medtronic (MDT) stake by 178% in Q2 2022, buying an estimated $357K and bringing the position to 5,499 shares worth $494K. The position accounts for 0.9% of the portfolio, ranked #29.
Pluribus Labs first reported a position in MDT in Q1 2022 and has held it in 2 quarters since. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.
- Pluribus Labs held 5,499 shares of Medtronic worth $494K as of Q2 2022.
- Pluribus Labs bought 3,524 Medtronic shares in Q2 2022, an estimated $357K.
- Medtronic made up 0.9% of Pluribus Labs's portfolio in Q2 2022, its #29 holding.
- Pluribus Labs first reported a position in Medtronic in Q1 2022 and has held it in 2 quarters since.
- 2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.
Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.